Swiss National Bank Mersana Therapeutics, Inc. Transaction History

Swiss National Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 09, 2023	BUY	$3.08 - $9.55 $17,864 - $55,390	5,800 Added 3.37%	178,096 $585,000
Q1 2023 May 10, 2023	SELL	$4.0 - $7.02 $61,600 - $108,108	-15,400 Reduced 8.2%	172,296 $708,000
Q4 2022 Feb 08, 2023	BUY	$5.65 - $7.86 $20,905 - $29,082	3,700 Added 2.01%	187,696 $1.1 Million
Q3 2022 Nov 09, 2022	BUY	$4.63 - $8.0 $27,780 - $48,000	6,000 Added 3.37%	183,996 $1.24 Million
Q2 2022 Aug 09, 2022	BUY	$2.84 - $5.0 $119,280 - $210,000	42,000 Added 30.88%	177,996 $822,000
Q1 2022 May 09, 2022	BUY	$3.74 - $6.63 $35,904 - $63,648	9,600 Added 7.6%	135,996 $543,000
Q4 2021 Feb 08, 2022	BUY	$5.48 - $9.86 $18,632 - $33,524	3,400 Added 2.76%	126,396 $786,000
Q3 2021 Nov 08, 2021	BUY	$8.56 - $14.47 $18,832 - $31,834	2,200 Added 1.82%	122,996 $1.16 Million
Q2 2021 Aug 06, 2021	SELL	$13.28 - $18.07 $59,760 - $81,315	-4,500 Reduced 3.59%	120,796 $1.64 Million
Q1 2021 May 07, 2021	BUY	$15.31 - $26.52 $24,496 - $42,432	1,600 Added 1.29%	125,296 $2.03 Million
Q4 2020 Feb 05, 2021	BUY	$16.84 - $27.59 $133,036 - $217,961	7,900 Added 6.82%	123,696 $3.29 Million
Q3 2020 Nov 09, 2020	BUY	$16.2 - $25.7 $59,940 - $95,090	3,700 Added 3.3%	115,796 $2.16 Million
Q2 2020 Aug 05, 2020	BUY	$5.24 - $23.4 $587,383 - $2.62 Million	112,096 New	112,096 $2.62 Million

136

101M

77.2K

453K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $51.5M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.